These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26986252)

  • 41. Knockdown of β-catenin expression inhibits neuroblastoma cell growth in vitro and in vivo.
    Yao W; Li K; Zheng S; Xiao X; Ma Y; Zhai X
    J Pediatr Surg; 2013 Dec; 48(12):2466-73. PubMed ID: 24314188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
    Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.
    Zhu Z; Liu Y; Li K; Liu J; Wang H; Sun B; Xiong Z; Jiang H; Zheng J; Hu Z
    Carcinogenesis; 2014 Aug; 35(8):1901-10. PubMed ID: 24876153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
    Wang ZM; Cui YH; Li W; Chen SY; Liu TS
    Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth inhibition and apoptosis of human B-cell lymphoma in vitro and in vivo by Bcl-2 short hairpin RNA.
    Liu Y; Shen Y; Qin C; Shi Y; Rong G; Yu X
    Oncol Rep; 2013 Jan; 29(1):244-52. PubMed ID: 23076380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hexokinase 2 regulates G1/S checkpoint through CDK2 in cancer-associated fibroblasts.
    Hu JW; Sun P; Zhang DX; Xiong WJ; Mi J
    Cell Signal; 2014 Oct; 26(10):2210-6. PubMed ID: 24780297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells.
    Wang R; Lin F; Wang X; Gao P; Dong K; Zou AM; Cheng SY; Wei SH; Zhang HZ
    Cancer Gene Ther; 2008 Jun; 15(6):402-12. PubMed ID: 18340356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hexokinase 2 in colorectal cancer: a potent prognostic factor associated with glycolysis, proliferation and migration.
    Katagiri M; Karasawa H; Takagi K; Nakayama S; Yabuuchi S; Fujishima F; Naitoh T; Watanabe M; Suzuki T; Unno M; Sasano H
    Histol Histopathol; 2017 Apr; 32(4):351-360. PubMed ID: 27363977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downregulating HK2 inhibits proliferation of endometrial stromal cells through a noncanonical pathway involving phosphorylation of signal transducer and activator of transcription 1 in endometriosis.
    Hou S; Lei S; Peng H; Weng L; Lv S; Li M; Zhao D
    Biol Reprod; 2022 Aug; 107(2):488-499. PubMed ID: 35470850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway.
    Zou Y; Du Y; Cheng C; Deng X; Shi Z; Lu X; Hu H; Qiu J; Jiang W
    Exp Cell Res; 2021 Jan; 398(1):112401. PubMed ID: 33253711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hexokinase 2 controls cellular stress response through localization of an RNA-binding protein.
    Courteau L; Crasto J; Hassanzadeh G; Baird SD; Hodgins J; Liwak-Muir U; Fung G; Luo H; Stojdl DF; Screaton RA; Holcik M
    Cell Death Dis; 2015 Aug; 6(8):e1837. PubMed ID: 26247723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion.
    Lee HJ; Li CF; Ruan D; He J; Montal ED; Lorenz S; Girnun GD; Chan CH
    Nat Commun; 2019 Jun; 10(1):2625. PubMed ID: 31201299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis.
    Zheng M; Wu C; Yang K; Yang Y; Liu Y; Gao S; Wang Q; Li C; Chen L; Li H
    Pharmacol Res; 2021 Feb; 164():105367. PubMed ID: 33307221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
    Yang T; Ren C; Qiao P; Han X; Wang L; Lv S; Sun Y; Liu Z; Du Y; Yu Z
    Oncogene; 2018 Nov; 37(45):5997-6009. PubMed ID: 29985480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 3-Bromopyruvic acid, a hexokinase II inhibitor, is an effective antitumor agent on the hepatoma cells : in vitro and in vivo findings.
    Gong L; Wei Y; Yu X; Peng J; Leng X
    Anticancer Agents Med Chem; 2014 Jun; 14(5):771-6. PubMed ID: 24738957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells.
    Tian X; Liu D; Zuo X; Sun X; Wu M; Li X; Teng Y
    J Ovarian Res; 2022 Aug; 15(1):92. PubMed ID: 35953860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New natural inhibitors of hexokinase 2 (HK2): Steroids from Ganoderma sinense.
    Bao F; Yang K; Wu C; Gao S; Wang P; Chen L; Li H
    Fitoterapia; 2018 Mar; 125():123-129. PubMed ID: 29305912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.
    Patra KC; Wang Q; Bhaskar PT; Miller L; Wang Z; Wheaton W; Chandel N; Laakso M; Muller WJ; Allen EL; Jha AK; Smolen GA; Clasquin MF; Robey B; Hay N
    Cancer Cell; 2013 Aug; 24(2):213-228. PubMed ID: 23911236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells.
    Agnihotri S; Mansouri S; Burrell K; Li M; Mamatjan Y; Liu J; Nejad R; Kumar S; Jalali S; Singh SK; Vartanian A; Chen EX; Karimi S; Singh O; Bunda S; Mansouri A; Aldape KD; Zadeh G
    Clin Cancer Res; 2019 Jan; 25(2):844-855. PubMed ID: 30322879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.